- Home
- XNCR vs CPF Comparison
XNCR vs CPF Comparison
Compare XNCR & CPF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | XNCR | CPF |
|---|---|---|
| Founded | 1997 | 1954 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 997.1M |
| IPO Year | 2013 | 2011 |
Fundamental Metrics
Financial Performance| Metric | XNCR | CPF |
|---|---|---|
| Price | $16.87 | $38.81 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 2 |
| Target Price | $22.33 | ★ $37.00 |
| AVG Volume (30 Days) | ★ 958.3K | 153.6K |
| Earning Date | 05-08-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 3.39% |
| EPS Growth | ★ 65.36 | 45.18 |
| EPS | N/A | ★ 0.78 |
| Revenue | ★ $125,576,000.00 | $51,817,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.80 | $4.62 |
| P/E Ratio | ★ N/A | $51.19 |
| Revenue Growth | 13.65 | ★ 33.81 |
| 52 Week Low | $6.92 | $25.62 |
| 52 Week High | $18.69 | $40.06 |
Technical Indicators
Market Signals| Indicator | XNCR | CPF |
|---|---|---|
| Relative Strength Index (RSI) | 71.16 | 61.84 |
| Support Level | $11.06 | $33.33 |
| Resistance Level | $18.69 | $39.20 |
| Average True Range (ATR) | 1.02 | 0.94 |
| MACD | -0.00 | 0.02 |
| Stochastic Oscillator | 97.16 | 62.06 |
Price Performance
Historical ComparisonAbout XNCR Xencor Inc.
Xencor Inc is a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab and XmAb657. The group earns its revenue from collaboration agreements and licensing agreements and operates as a single reportable segment focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases who have unmet medical needs.
About CPF Central Pacific Financial Corp New
Central Pacific Financial Corp operates in the financial services sector in the United States. It is a full-service commercial bank offering a broad range of banking products and services, including accepting time and demand deposits and originating loans. Bank's deposits are insured by the Federal Deposit Insurance Corporation (FDIC) up to applicable limits. The bank is not a member of the Federal Reserve System. The company's loans include commercial loans, construction loans, commercial and residential mortgage loans, and consumer loans. The company derives income from interest and fees on loans, interest on investment securities, and fees received in connection with deposits and other services. It operates in single segment which is Banking operations.